First Manhattan’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4
| Closed | -$957 | – | 1416 |
|
|
2023
Q4 | $957 | Buy |
+4
| New | +$957 | ﹤0.01% | 1333 |
|
|
2020
Q1 | – | Sell |
-10
| Closed | -$1K | – | 1361 |
|
|
2019
Q4 | $1K | Buy |
+10
| New | +$1K | ﹤0.01% | 1262 |
|
|
2016
Q4 | – | Sell |
-2,000
| Closed | -$135K | – | 1365 |
|
|
2016
Q3 | $135K | Hold |
2,000
| – | – | ﹤0.01% | 741 |
|
|
2016
Q2 | $110K | Hold |
2,000
| – | – | ﹤0.01% | 795 |
|
|
2016
Q1 | $125K | Hold |
2,000
| – | – | ﹤0.01% | 745 |
|
|
2015
Q4 | $188K | Hold |
2,000
| – | – | ﹤0.01% | 684 |
|
|
2015
Q3 | $160K | Hold |
2,000
| – | – | ﹤0.01% | 708 |
|
|
2015
Q2 | $239K | Hold |
2,000
| – | – | ﹤0.01% | 657 |
|
|
2015
Q1 | $208K | Hold |
2,000
| – | – | ﹤0.01% | 680 |
|
|
2014
Q4 | $194K | Hold |
2,000
| – | – | ﹤0.01% | 705 |
|
|
2014
Q3 | $156K | Hold |
2,000
| – | – | ﹤0.01% | 725 |
|
|
2014
Q2 | $126K | Hold |
2,000
| – | – | ﹤0.01% | 770 |
|
|
2014
Q1 | $134K | Buy |
2,000
+1,000
| +100% | +$67K | ﹤0.01% | 742 |
|
|
2013
Q4 | $64K | Buy |
+1,000
| New | +$64K | ﹤0.01% | 882 |
|